Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Evaluation of a Proposed Method for Representing Drug Terminology James J. Cimino, Timothy J. McNamara, Terri Meredith, Carol A. Broverman, Karen C. Eckert Drug Terminology Efforts in HL7 • Need for medication terms • Much source data generated by pharmacy systems • Pharmacy knowledge base vendors are exploring ways to place their terminologies in the public domain • Vocabulary TC convened meetings to explore ways of collaborating Disclaimer • Nothing is a balloted standard yet • TC has not yet proposed a formal model • TC has not yet proposed a plan of action • TC is still defining scope and goals Drug Model Hierarchy Packages Medications Drug Class Chemicals International Package Identifiers is-a Not-Fully-Specified Drug Ingredient Class is-a Country-Specific Packaged Product Clinical Drug is-a Ingredient is-a is-a Trademark Drug is-a Manufactured Components is-a Composite Clinical Drug is-a Composite Trademark Drug Drug Model Hierarchy Packages Medications Drug Class Chemicals International Package Identifiers is-a Not-Fully-Specified Drug Ingredient Class is-a Country-Specific Packaged Product Clinical Drug is-a Ingredient is-a is-a Trademark Drug is-a Manufactured Components is-a Composite Clinical Drug is-a Composite Trademark Drug Clinical Drugs • Dosage form • Active ingredients – Chemical – Form Strength • Strength amount • Strength units • Volume • Volume units Experiment • Can model allow for interoperability? – Single terminology vs. – Mapping between terminologies • Select random sample of drug terms • Obtain descriptions from terminology developers • Compare description components • Examine overall match rate Sample Selection • 71,000 NDC Codes • 1000 selected at random (1.4%) • Many are obsolete Descriptions from Vendors Name Form Ingredient 1 Valium 5mg Tablet Tablet Diazepam ^5^mg Tylenol #3 Tablet Acetaminophen ^325^mg Chloral Hydrate Syrup Syrup Ingredient 2 Codeine ^30^mg Chloral Hydrate 100.000000^mg^1.000000^ml Descriptions from Vendors Set A B C D E Mapped 358 459 605 405 566 A 340 358 326 357 B 340 452 361 449 C 358 452 393 554 D 326 361 393 392 E 357 449 554 392 - None 642 541 395 395 434 Overall, 367 terms were not represented in any set, 71 appeared in only one set, 77 appeared in exactly two sets, 83 appeared in three sets, 91 appeared in four, and 311 terms appeared in all five terminologies. Pairwise Comparisons Set A B C D E B C D E 340 358 326 357 452 361 449 393 554 392 Pairwise Comparisons Set A B C D E 3982 B C D E 340 358 326 357 452 361 449 393 554 392 { Comparisons • Dosage Form: 3982 • Ingredient (number and match): 5507 • Dose Strength (dose, units, volume, volume units): 4337 • Overall: 3982 Dosage Form Matching • TAB = TABLET • LIQUID ORAL LIQUID • 111 Dosage form synonyms Ingredient Matching • HCl vs. Hydrochloride • Salt vs. Base • Inclusion of form or route • Mention of animal source Dose Strength Matching • Standard format (000050000 vs. 500.00) • Normalization of units (GM vs. MG) Dose Units Matching • Standard abbreviations • Normalization of units (GM vs. MG) • Missing values • Inclusion of concentration information • MG vs. % Dose Volume Matching • Not given • Different numeric formats • Defaults (0 and 1) • Different volumes ( per 1ml vs per 5ml) Dose Volume Units Matching • Not given • “Each” • Different abbreviations Overall Matching • Form matches • Same number of ingredients • Each ingredient matches on chemical and all four other parameters Overall Matching Total Before Conversion After Conversion Components: Ingredients Strength Units Volume Volume Units 5507 4337 4337 4337 4337 3607 (65%) 374 (9%) 1845 (43%) 1054 (24%) 2319 (53%) 4337 (79%) 3262 (75%) 2964 (68%) 3754 (87%) 3486 (80%) Overall: Each Ingred All Ingred Dose Form Complete Drug 4337 3982 3982 3982 0 (0%) 0 (0%) 645 (16%) 0 (0%) 2773 (64%) 2519 (63%) 2859 (72%) 2128 (53%) 53% Pairwise Comparisons Set A B C D E A 340 358 326 357 B 340 452 361 449 C 358 452 393 554 D 326 361 393 392 E 357 449 554 392 - Pairwise Complete Matches Set A B C D E A 59% 45% 48% 52% B 59% 54% 63% 62% C 45% 54% 46% 48% D 48% 63% 46% 58% E 52% 62% 48% 58% - Example of Mismatch GUAIFENESIN AC LIQUID|10;100|MG/5ML;MG/|LIQUID SYRUP| GUAIFENESIN^00000000.000^^0000.000^ CODEINE PHOSPHATE^.^^.^ LIQUID| CODEINE PHOSPHATE^2.000000^MG^^ GUAIFENESIN^20.000000^MG^1.000000^ML LIQUID, ORAL (SYSTEMIC)| CODEINE PHOSPHATE^10^MG^5^ML GUAIFENESIN^100^MG^5^ML LIQUID| CODEINE PHOSPHATE^10.0000^MG/5ML^^ GUAIFENESIN^100.0000^MG/5ML^^ SYRUP| CODEINE PHOSPHATE^10^MILLIGRAM(S)^5^MILLILITER(S) GUAIFENESIN^100^MILLIGRAM(S)^5^MILLILITER(S) Example of Mismatch BUMEX INJECTION|0.25|MG|INJ-SOL AMPUL BUMETANIDE^00000000.250^MG^0001.000^ML INJECTION SODIUM CHLORIDE, IV USE^0.850000^%^^ BUMETANIDE, INJECTABLE^0.250000^MG^1.000000^ML INJECTION BUMETANIDE^0.25^MG^1^ML SOLUTION BUMETANIDE^0.2500^MG/ML^^ SOLUTION BUMETANIDE^0.25^MILLIGRAM(S)^1^MILLILITER(S) Example of Mismatch RECOMBIVAX HB ADULT FORMULATION INJECTION|10|MCG|INJ-SUS VIAL HEPATITIS B VIRUS VACCINE^00000010.000^MCG^0001.000^ML INJECTION HEPATITIS B SURFACE ANTIGEN^10.000000^MCG^1.000000^ML INJECTION HEPATITIS B VACCINE-RECOMBINANT^10^MCG^1^ML INJECTION HEPATITIS B VIRUS VACCINE RECOMBINANT^10.0000^MCG/ML ^^ SOLUTION HEPATITIS B VACCINE RECOMBINANT^10^MICROGRAM(S)^ 1^MILLILITER(S) Focus on Dosage Form • 3982 comparisons • 111 synonyms • 72% match rate • What went wrong? Examination of Dosage Forms • Compare use of each form, in each source, with use in other sources for corresponding medications • Look for irregularities in source • Look for 100% agreement • When not 100% agreement, look at hierarchical subsumption Irregularities in Sources NDC: 0000153144|FLUORITAB TABLETS CHEWABLE CHERRY|1.1|MG| TAB CHEW|100|BOT: A:: |FLUORITAB 0.5MG TABLET CHEW^SODIUM FLUORIDE| CHEWABLE TABLET|SODIUM FLUORIDE^00000000.500^MG ^0000.000^ B: |FLUORITAB CHERRY TABS CHEW, 0.5MG|CHEWABLE SODIUM FLUORIDE^1.100000^MG^^ TABLET| C: |SODIUM FLUORIDE CHEW TAB 1.1 MG (0.5MG F)|CHEWABLE TABLET|SODIUM FLUORIDE^1.1000^MG^^ D: ||TABLET|SODIUM FLUORIDE^0.5^MG^^ Near Misses and the Hierarchy Tablet Sodium Fluoride 1.1 MG Tablet is-a Chewable Tablet A is-a Sodium Fluoride 1.1 MG Chewable Tablet B C D Irregularities in Sources NDC: 0000014889|PROPRANOLOL HYDROCHLORIDE EXTENDED RELEASE CAPSULES|80|MG|CAP ER|100|BOT A: ||CAPSULE CR|PROPRANOLOL HYDROCHLORIDE^80^MG^^ B: |PROPRANOLOL 80MG CAPSULE SA^PROPRANOLOL HCL| CAPSULE CR|PROPRANOLOL HCL^00000080.000^MG^0000.000^ C:: |PROPRANOLOL HCL CAP CR 80 MG|CAPSULE PROPRANOLOL HYDROCHLORIDE^80.0000^MG^^ CR| D:: |PROPRANOLOL HYDROCHLORIDE^80 MG|CAPSULE CR| PROPRANOLOL HYDROCHLORIDE^80^MILLIGRAM(S)^1^EACH E:: |PROPRANOLOL HCL TABS CR, 80MG|TABLET HYDROCHLORIDE^80.000000^MG^^ CR|PROPRANOLOL Example of 100% Agreement A: LOTION: 1: LOTION| B: LOTION: 1: LOTION| C: LOTION: 1: LOTION| D: LOTION: 1: LOTION| E: LOTION: 1: LOTION| Example of 100% Agreement A: TABLET CR: 14: TAB E REL|TAB FC ER B: TABLET CR: 6: TAB FC ER|TAB SUG CO| C: TABLET CR: 9: TAB FC ER|TAB E REL| D: TABLET CR: 14: TAB E REL|TAB FC ER|TAB FC| E: TABLET CR: 7: TAB FC ER|TAB E REL| Example of <100% Agreement A: AEROSOL: 2: INHALANT|AEROSL SPR| B: AEROSOL: 1: INHALANT| C: AEROSOL: 1: INHALANT| SPRAY, TOPICAL, DERMAL: 1: AEROSL SPR| D: AEROSOL: 2: INHALANT|AEROSL SPR| E: AEROSOL: 1: INHALANT| Handling Ambiguity Aerosol A D Terbutaline Sulfate 0.2mg/ACT Aerosol is-a B C E Terbutaline Sulfate 0.2mg/ACT Inhaled Aerosol is-a Inhaled Dermal Aerosol Aerosol Triamcinolone Acetonide 0.147mg/GM Aerosol A is-a Triamcinolone Acetonide 0.147mg/GM Dermal Aerosol C Example of Subsumption Aerosol (): A(AEROSOL) D(AEROSOL) Inhaled Aerosol (INHALENT): B(AEROSOL) C(AEROSOL) E(AEROSOL) Dermal Aerosol (AEROSL SPR): C(SPRAY TOPICAL, DERMAL) No Solution for Solution AMPUL DROPS INFUS. BTL INJECTION IRRIGATION SOLUTION IV SOLN. KIT PIGGYBACK PLAST. BAG SKIN TEST SOLUTION SYRUP VIAL ELIXIR INJ REPOSITORY INJECTION INJECTION TYPE INJECTION IVPB KIT LIQUID SOLUTION SUSPENSION CONCENTRATE INJECTION KIT NEBU OIL SOLUTION SYRUP DROPS, OPHTHALMIC (NON-SYSTEMIC) INJECTION IRRIGATION SOLUTION KIT, INJECTION (SYSTEMIC) SOLUTION FOR DROPS, OTIC SOLUTION FOR INHALATION... SOLUTION OPHTMALMIC… SOLUTION, ORAL (SYSTEMIC) SOLUTION, OTIC SOLUTION, TOPICAL, DERMAL SYRUP Discussion • Matching is still far from perfect • Not surprising, given lack of standards for attribute values • Next steps Discussion: Next Steps • Define some rules for each field • Select new random sample • Find subset with good overlap across terminologies • Submit descriptions of new subset Discussion: New Rules • Dose forms: separate translation step • Ingredients: – Right number – Specific chemical entity – Identifiers (UMLS?) – Don’t mix in route or concentration • Strengths: – Conversion algorithms – Rules for defaults – Don’t mix route or concentration with strength Conclusions • Glass half empty: – How can we do automated translation of patient data? – Can drug order transfers and decision support be safe? • Glass half full: – No attempt yet to standardize attribute terminology – Most translation was much better than 50% – Just getting started – Better than what we do now